Please login to the form below
ASP015K
This page shows the latest ASP015K news and features for those working in and with pharma, biotech and healthcare.
Latest Intelligence
-
Deal Watch table for December 2014
Company acquisition. 3, 500. Astellas/ J&J. ASP015K, an oral JAK inhibitor for RA (p3).
-
Pharma deals during October 2012
Heading the deal table is the $945m licence between Astellas Pharma and Janssen for the exclusive rights outside Japan to ASP015K, an oral janus kinase (JAK) inhibitor that is undergoing phase ... Astellas / Janssen. Licence. ASP015K for RA, psoriasis
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Business Director
-
Competitive Salary Offered
- Principal Health Economist - North-West
-
Negotiable
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
-
Associate Director
-
£75, 000-90, 000
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Account Manager
-
Negotiable
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Systematic Reviewer - Oxford
-
Negotiable
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Business Development Director – Health Education
-
excellent commission
-
Account Manager / Account Director
-
Competative
-
Medical Writer
-
Salary TBC
- Account Manager- Healthcare Advertising
-
Negotiable
-
Account Director
-
Competitive Salary Offered
-
Medical (Scientific) Director
-
£120, 000 benefits
Subscribe to our email news alerts
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Is China ready for a pharmaceutical gold rush?
- Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Quick links
Infographics
